✓ Last verified: January 28, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: Toledo’s dedicated physician-led Spravato practice — board-certified psychiatrist Dr. Kettlie Daniels offers in-network insurance billing across Aetna, Anthem BCBS, Cigna, UnitedHealthcare, and TRICARE for treatment-resistant depression care.
| Review Scores | Dedicated Toledo MD-led Spravato practice with in-network insurance coverage |
| Location | Toledo, OH |
| Address | 980 S Byrne Road, Toledo, OH 43609 |
| Phone | (419) 842-0140 |
| Website | mddcare.com |
| Treatments | Spravato (Esketamine) Nasal Spray, Psychiatric Medication Management |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder, Depression |
| Cost | Contact for pricing; insurance typically covers Spravato |
| Insurance | In-network with Aetna, Anthem Blue Cross/Blue Shield, Cigna, OPTUM/UnitedHealthcare (Commercial & Medicare Advantage), TRICARE |
| Clinical Lead | Dr. Kettlie Joseph Daniels, MD — Board-certified psychiatrist |
💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.
HealingMaps Take: Dr. Kettlie Daniels’s Spravato practice fills the MD-led interventional psychiatry gap in Toledo. With only one existing IV ketamine option in the market (Northwest Ohio Ketamine) and no other well-established Spravato provider, Dr. Daniels’s practice gives Toledo patients access to insurance-covered esketamine therapy under the direct care of a board-certified psychiatrist rather than a nurse practitioner or PA. That distinction matters for patients with complex presentations — comorbid medical conditions, complicated medication regimens, or previous treatment failures — where physician-level clinical judgment is most valuable. The in-network insurance breadth is a major differentiator: Aetna, Anthem BCBS, Cigna, OPTUM/UnitedHealthcare (including Medicare Advantage), and TRICARE covers essentially every major plan a Toledo patient is likely to have. Most interventional psychiatry practices are cash-only; having an MD-led Spravato program that’s in-network with nearly every major insurer makes treatment realistically affordable for middle-class and working-class Toledo patients with treatment-resistant depression. The South Byrne Road location in South Toledo is accessible from I-75 and serves Maumee, Perrysburg, and the southern Toledo metro. Standard business hours (Monday-Friday 8 AM to 5 PM) work for most patients.
Market Position: Dr. Kettlie Joseph Daniels, MD (Spravato) is a Spravato-certified clinic in the Toledo metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Dr. Kettlie Joseph Daniels, MD (Spravato) has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Dr. Kettlie Joseph Daniels, MD (Spravato) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Dr. Kettlie Joseph Daniels, MD (Spravato) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Dr. Kettlie Joseph Daniels, MD (Spravato) treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Leave a Reply